HIGH RISK NEUROBLASTOMA

Clinical trials for HIGH RISK NEUROBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new HIGH RISK NEUROBLASTOMA trials appear

Sign up with your email to follow new studies for HIGH RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

New Two-Drug attack tested for tough childhood cancers

Disease control Completed

This early-phase study tested the safety and best dose of two antibody drugs, magrolimab and dinutuximab, given together to children and young adults whose neuroblastoma or osteosarcoma had come back or stopped responding to other treatments. The main goal was to see if the combi…

Matched conditions: HIGH RISK NEUROBLASTOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 12, 2026 13:51 UTC

HIGH RISK NEUROBLASTOMA

Get alerted when new HIGH RISK NEUROBLASTOMA trials appear

New Two-Drug attack tested for tough childhood cancers